DEF 14A: RenovoRx Sets Date for 2024 Annual Stockholders Meeting
Proxy Statement
RenovoRx will hold its 2024 Annual Meeting of Stockholders on June 6, 2024, to elect directors and conduct other business.
Summary
- RenovoRx, Inc. will hold its 2024 Annual Meeting of Stockholders on Thursday, June 6, 2024, at 9:00 a.m. Pacific Time in Menlo Park, California.
- Stockholders of record as of April 11, 2024, are entitled to vote at the meeting.
- The meeting's agenda includes the election of six members to the Board of Directors to serve until the 2025 Annual Meeting and to vote upon such other business as may properly come before the Annual Meeting.
- The Board of Directors recommends voting FOR the election of all six nominees.
- Proxy materials, including the Proxy Statement and the 2023 Annual Report, are available on the company's website and were first mailed on or about May 3, 2024.
- Stockholders can vote by telephone, electronically over the Internet, or via mail by returning the signed proxy card.
Sentiment
Score: 7
Explanation: The document is a standard corporate communication with a neutral to slightly positive tone due to the expression of gratitude to stockholders.
Positives
- The Board of Directors unanimously recommends voting FOR all director nominees, indicating confidence in their abilities.
- Stockholders have multiple options for voting, including telephone, internet, and mail, making it convenient to participate.
Future Outlook
The document outlines the procedures and deadlines for stockholder proposals and director nominations for the 2025 Annual Meeting.
Management Comments
- Shaun R. Bagai, Chief Executive Officer, thanks stockholders for their continued support and looks forward to seeing them at the Annual Meeting.
Industry Context
This is a standard proxy statement related to the annual meeting of stockholders, a routine event for publicly traded companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Principal Accounting Officer | NA | Ronald B. Kocak | February 8, 2024 | Appointment |
| Chief Clinical Officer | NA | Leesa Gentry | March 1, 2024 | Appointment |
| Chief Operating Officer | Angela Helms | NA | March 1, 2024 | Resignation |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy | Amended and restated insider trading policy and procedures governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees. | September 7, 2023 | Designed to promote compliance with insider trading laws, rules and regulations, and applicable Nasdaq listing standards. |
| Compensation Recovery Policy | Policy (commonly known as a clawback policy) which provides for the recovery of erroneously awarded incentive compensation to certain of our officers in the event that we are required to prepare an accounting restatement due to material noncompliance by us with any financial reporting requirements under the federal securities laws. | September 7, 2023 | Designed to comply with Section 10D of the Exchange Act, related rules and the listing standards of Nasdaq or any other securities exchange on which our shares are listed in the future. |
Stakeholder Impact
- Shareholders are asked to vote on the election of directors, which will influence the company's governance and strategic direction.
- Executive compensation decisions impact the alignment of management's interests with those of the shareholders.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on June 6, 2024.
- The company will announce voting results after the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| April 11, 2024 | Record date for determining stockholders eligible to vote |
| April 30, 2024 | Proxy Statement dated |
| April 30, 2024 | Proxy Statement and 2023 Annual Report are being made available on or about this date |
| May 3, 2024 | Proxy materials are being mailed on or about this date |
| June 5, 2024 | Deadline to revoke or change vote by written statement |
| June 5, 2024 | Internet voting facilities close at 11:59 p.m. Eastern Time |
| June 6, 2024 | Annual Meeting of Stockholders at 9:00 a.m. Pacific Time |
| March 8, 2025 | Deadline for stockholder proposals for the 2025 Annual Meeting |
| February 6, 2025 | Earliest date for advance notice of stockholder proposals for the 2025 Annual Meeting |
| March 8, 2025 | Latest date for advance notice of stockholder proposals for the 2025 Annual Meeting |
Keywords
Annual Meeting, Stockholders, Board of Directors, Proxy Statement, Election of Directors, RenovoRx
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.